vs
Pediatrix Medical Group, Inc.（MD）与SELECT MEDICAL HOLDINGS CORP（SEM）财务数据对比。点击上方公司名可切换其他公司
SELECT MEDICAL HOLDINGS CORP的季度营收约是Pediatrix Medical Group, Inc.的2.8倍（$1.4B vs $493.8M）。Pediatrix Medical Group, Inc.净利率更高（6.8% vs 1.4%，领先5.4%）。SELECT MEDICAL HOLDINGS CORP同比增速更快（6.4% vs -1.7%）。过去两年SELECT MEDICAL HOLDINGS CORP的营收复合增速更高（2.8% vs -0.1%）
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
Select Medical是总部位于美国宾夕法尼亚州的医疗健康企业，业务涵盖长期急症护理、住院康复医院运营，同时开设有职业健康与物理治疗诊所，母公司Select Medical Holdings在纽约证券交易所挂牌上市。
MD vs SEM — 直观对比
营收规模更大
SEM
是对方的2.8倍
$493.8M
营收增速更快
SEM
高出8.1%
-1.7%
净利率更高
MD
高出5.4%
1.4%
两年增速更快
SEM
近两年复合增速
-0.1%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $493.8M | $1.4B |
| 净利润 | $33.7M | $20.2M |
| 毛利率 | — | — |
| 营业利润率 | 9.9% | 4.6% |
| 净利率 | 6.8% | 1.4% |
| 营收同比 | -1.7% | 6.4% |
| 净利润同比 | 10.5% | 225.7% |
| 每股收益（稀释后） | $0.40 | $0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDSEM
| Q4 25 | $493.8M | $1.4B | ||
| Q3 25 | $492.9M | $1.4B | ||
| Q2 25 | $468.8M | $1.3B | ||
| Q1 25 | $458.4M | $1.4B | ||
| Q4 24 | $502.4M | $1.3B | ||
| Q3 24 | $511.2M | $1.3B | ||
| Q2 24 | $504.3M | $1.3B | ||
| Q1 24 | $495.1M | $1.3B |
净利润MDSEM
| Q4 25 | $33.7M | $20.2M | ||
| Q3 25 | $71.7M | $28.8M | ||
| Q2 25 | $39.3M | $40.6M | ||
| Q1 25 | $20.7M | $56.7M | ||
| Q4 24 | $30.5M | $-16.1M | ||
| Q3 24 | $19.4M | $55.6M | ||
| Q2 24 | $-153.0M | $77.6M | ||
| Q1 24 | $4.0M | $96.9M |
营业利润率MDSEM
| Q4 25 | 9.9% | 4.6% | ||
| Q3 25 | 13.8% | 5.4% | ||
| Q2 25 | 12.8% | 6.5% | ||
| Q1 25 | 7.0% | 8.3% | ||
| Q4 24 | 7.8% | 1.6% | ||
| Q3 24 | 6.6% | 4.3% | ||
| Q2 24 | -31.3% | 5.8% | ||
| Q1 24 | 3.2% | 9.0% |
净利率MDSEM
| Q4 25 | 6.8% | 1.4% | ||
| Q3 25 | 14.5% | 2.1% | ||
| Q2 25 | 8.4% | 3.0% | ||
| Q1 25 | 4.5% | 4.2% | ||
| Q4 24 | 6.1% | -1.2% | ||
| Q3 24 | 3.8% | 4.4% | ||
| Q2 24 | -30.3% | 6.1% | ||
| Q1 24 | 0.8% | 7.3% |
每股收益（稀释后）MDSEM
| Q4 25 | $0.40 | $0.17 | ||
| Q3 25 | $0.84 | $0.23 | ||
| Q2 25 | $0.46 | $0.32 | ||
| Q1 25 | $0.24 | $0.44 | ||
| Q4 24 | $0.37 | $-0.12 | ||
| Q3 24 | $0.23 | $0.43 | ||
| Q2 24 | $-1.84 | $0.60 | ||
| Q1 24 | $0.05 | $0.75 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $375.2M | $26.5M |
| 总债务越低越好 | $570.5M | $1.8B |
| 股东权益账面价值 | $865.9M | $1.7B |
| 总资产 | $2.2B | $5.9B |
| 负债/权益比越低杠杆越低 | 0.66× | 1.06× |
8季度趋势，按日历期对齐
现金及短期投资MDSEM
| Q4 25 | $375.2M | $26.5M | ||
| Q3 25 | $340.1M | $60.1M | ||
| Q2 25 | $224.7M | $52.3M | ||
| Q1 25 | $99.0M | $53.2M | ||
| Q4 24 | $229.9M | $59.7M | ||
| Q3 24 | $103.8M | $191.5M | ||
| Q2 24 | $19.4M | $111.2M | ||
| Q1 24 | $8.0M | $92.6M |
总债务MDSEM
| Q4 25 | $570.5M | $1.8B | ||
| Q3 25 | $577.2M | $1.7B | ||
| Q2 25 | $583.9M | $1.8B | ||
| Q1 25 | $590.5M | $1.8B | ||
| Q4 24 | $597.1M | $1.7B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.6B | ||
| Q1 24 | — | $3.8B |
股东权益MDSEM
| Q4 25 | $865.9M | $1.7B | ||
| Q3 25 | $890.7M | $1.7B | ||
| Q2 25 | $833.8M | $1.7B | ||
| Q1 25 | $789.2M | $1.7B | ||
| Q4 24 | $764.9M | $1.7B | ||
| Q3 24 | $732.5M | $1.9B | ||
| Q2 24 | $706.5M | $1.4B | ||
| Q1 24 | $856.2M | $1.4B |
总资产MDSEM
| Q4 25 | $2.2B | $5.9B | ||
| Q3 25 | $2.2B | $5.7B | ||
| Q2 25 | $2.1B | $5.7B | ||
| Q1 25 | $2.0B | $5.7B | ||
| Q4 24 | $2.2B | $5.6B | ||
| Q3 24 | $2.1B | $8.0B | ||
| Q2 24 | $2.0B | $7.9B | ||
| Q1 24 | $2.2B | $7.9B |
负债/权益比MDSEM
| Q4 25 | 0.66× | 1.06× | ||
| Q3 25 | 0.65× | 1.03× | ||
| Q2 25 | 0.70× | 1.10× | ||
| Q1 25 | 0.75× | 1.03× | ||
| Q4 24 | 0.78× | 1.01× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | 2.54× | ||
| Q1 24 | — | 2.75× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.1M | $64.3M |
| 自由现金流经营现金流 - 资本支出 | — | $5.2M |
| 自由现金流率自由现金流/营收 | — | 0.4% |
| 资本支出强度资本支出/营收 | — | 4.2% |
| 现金转化率经营现金流/净利润 | 3.39× | 3.19× |
| 过去12个月自由现金流最近4个季度 | — | $117.2M |
8季度趋势，按日历期对齐
经营现金流MDSEM
| Q4 25 | $114.1M | $64.3M | ||
| Q3 25 | $137.3M | $175.3M | ||
| Q2 25 | $137.2M | $110.3M | ||
| Q1 25 | $-117.5M | $-3.5M | ||
| Q4 24 | $133.0M | $125.4M | ||
| Q3 24 | $91.8M | $181.0M | ||
| Q2 24 | $107.0M | $278.2M | ||
| Q1 24 | $-125.2M | $-66.7M |
自由现金流MDSEM
| Q4 25 | — | $5.2M | ||
| Q3 25 | — | $122.2M | ||
| Q2 25 | — | $45.6M | ||
| Q1 25 | — | $-55.8M | ||
| Q4 24 | — | $62.0M | ||
| Q3 24 | — | $130.3M | ||
| Q2 24 | — | $222.6M | ||
| Q1 24 | — | $-119.2M |
自由现金流率MDSEM
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 9.0% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | -4.1% | ||
| Q4 24 | — | 4.7% | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 17.4% | ||
| Q1 24 | — | -9.0% |
资本支出强度MDSEM
| Q4 25 | — | 4.2% | ||
| Q3 25 | — | 3.9% | ||
| Q2 25 | — | 4.8% | ||
| Q1 25 | — | 3.9% | ||
| Q4 24 | — | 4.8% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | — | 4.0% |
现金转化率MDSEM
| Q4 25 | 3.39× | 3.19× | ||
| Q3 25 | 1.91× | 6.09× | ||
| Q2 25 | 3.49× | 2.72× | ||
| Q1 25 | -5.66× | -0.06× | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | 3.25× | ||
| Q2 24 | — | 3.59× | ||
| Q1 24 | -31.03× | -0.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
